NADPH oxidase 5 has a crucial role in cellular motility of colon cancer cells

2021 ◽  
Vol 59 (2) ◽  
Author(s):  
Naoki Ashizawa ◽  
Hiroki Shimizu ◽  
Katsutoshi Shoda ◽  
Shinji Furuya ◽  
Hidenori Akaike ◽  
...  
2016 ◽  
Vol 76 (4) ◽  
pp. 855-865 ◽  
Author(s):  
Jung Hee Joo ◽  
Hyunjin Oh ◽  
Myungjin Kim ◽  
Eun Jung An ◽  
Rae-Kwon Kim ◽  
...  

2010 ◽  
Vol 5 (10) ◽  
pp. 981-993 ◽  
Author(s):  
Davide Gianni ◽  
Nicolas Taulet ◽  
Hui Zhang ◽  
Celine DerMardirossian ◽  
Jeremy Kister ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 1757
Author(s):  
Krishnendu K. Roy ◽  
Jiamo Lu ◽  
James H. Doroshow

Recent studies suggest that of the molecules postulated to function as inhibitors of the NADPH oxidase family of enzymes iodonium analogs known to broadly interfere with flavin dehydrogenase function demonstrate mechanistic validity as NADPH oxidase poisons. In recent work, we have produced a series of novel iodonium compounds as putative inhibitors of these oxidases. To evaluate the potential utility of two novel molecules with favorable chemical properties, NSC 740104 and NSC 751140, we compared effects of these compounds to the two standard inhibitors of this class, diphenyleneiodonium and di-2-thienyliodonium, with respect to antiproliferative, cell cycle, and gene expression effects in human colon cancer cells that require the function of NADPH oxidase 1. Both new agents blocked NADPH oxidase-related reactive oxygen production, inhibited tumor cell proliferation, produced a G1/S block in cell cycle progression, and inhibited NADPH oxidase 1 expression at the mRNA and protein levels at low nM concentrations in a fashion similar to or better than the parent molecules. These studies suggest that NSC 740104 and NSC 751140 should be developed further as mechanistic tools to better understand the role of NADPH oxidase inhibition as an approach to the development of novel therapeutic agents for colon cancer.


2010 ◽  
Vol 10 (1) ◽  
pp. 24 ◽  
Author(s):  
Rebecca Rapier ◽  
Jameela Huq ◽  
Ramana Vishnubhotla ◽  
Marinka Bulic ◽  
Cecile M Perrault ◽  
...  

2020 ◽  
Vol 21 (10) ◽  
pp. 3420
Author(s):  
Shinan Li ◽  
Trong Thuan Ung ◽  
Thi Thinh Nguyen ◽  
Dhiraj Kumar Sah ◽  
Seon Young Park ◽  
...  

Matrix metalloproteinase-9 (MMP-9) plays a crucial role in cell invasion and cancer metastasis. In this study, we showed that cholic acid (CA), a major primary bile acid, can induce MMP-9 expression in colon cancer HT29 and SW620 cells. CA increased reactive oxygen species (ROS) production and also activated phosphorylation of ERK1/2, JNK, and p38 MAPK. Specific inhibitors and mutagenesis studies showed that ERK1/2 and JNK functioned as upstream signals in the activation of AP-1, and p38 MAPK functioned as an upstream signal in the activation of NF-κB. N-acetyl-L-cysteine (NAC, an ROS scavenger) and diphenyleneiodonium chloride (DPI, an NADPH oxidase inhibitor) inhibited CA-induced activation of ERK1/2, JNK, and p38 MAPK, indicating that ROS production by NADPH oxidase could be the furthest upstream signal in MMP-9 expression. Colon cancer cells pretreated with CA showed remarkably enhanced invasiveness. Such enhancement was partially abrogated by MMP-9-neutralizing antibodies. These results demonstrate that CA could induce MMP-9 expression via ROS-dependent ERK1/2, JNK-activated AP-1, and p38-MAPK-activated NF-κB signaling pathways, which in turn stimulate cell invasion in human colon cancer cells.


Oncotarget ◽  
2017 ◽  
Vol 8 (24) ◽  
pp. 38113-38135 ◽  
Author(s):  
Han Liu ◽  
Smitha Antony ◽  
Krishnendu Roy ◽  
Agnes Juhasz ◽  
Yongzhong Wu ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A493-A493
Author(s):  
J HARDWICK ◽  
G VANDENBRINK ◽  
S VANDEVENTER ◽  
M PEPPELENBOSCH

Sign in / Sign up

Export Citation Format

Share Document